The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.

In obese prostate cancer patients, robotic-assisted surgery to remove the prostate reduces the risk of blood loss and prolonged hospital stays, a Loyola Medicine study has found. The study by senior ...

Although minimally invasive prostate removal aided by a robot can lead to less blood loss, shorter hospital stays and fewer complications, there is no evidence that the procedure improves cure rates, ...

ASA: Ocular Injuries Up With Robotic-Assisted Prostatectomy Higher rate of ocular injuries, including corneal abrasions, in surgeries using the robotic approach For patients undergoing radical ...

UK surgeons remotely removed a man’s prostate cancer from 1,500 miles away in the country’s first successful robot-assisted telesurgery.

When it comes to treatment for prostate cancer, men have a range of options, from active surveillance to radiation to surgery, just to name a few. Which approach to choose is a highly personal ...

CT scan in a patient 1 month following robotic prostatectomy Robotic-assisted radical prostatectomy is associated with higher costs than open radical prostatectomy at the index hospitalization for the ...

Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer Completed surveys were obtained from 685 (86%) of 797 ...

At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...

A phase I open-label, dose escalation study to determine the maximum tolerated dose and to evaluate the safety profile of lenalidomide with every three week docetaxel in subjects with androgen ...